Table 3 The relationship between B7-H3 in pancreatic cancer tissue and associated clinical pathological factors
From: Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer
Pathologic parameter | Cases(N) | B7-H3 expression positive rate % | χ2 | P value |
|---|---|---|---|---|
Male | 27 | 81.5 (22/27) | 0.536 | 0.464 |
Female | 18 | 72.2 (13/18) | ||
Age < 60 | 19 | 73.7 (14/19) | 0.319 | 0.572 |
Age ≥60 | 26 | 80.8 (21/26) | ||
Located in head | 37 | 81.1 (30/37) | 0.257 | 0.612 |
Located in tail | 6 | 66.7 (4/6) | ||
Whole pancreas cancer | 2 | 50 (1/2) | ||
Size of primary carcinoma(<3 cm) | 30 | 86.7 (26/30) | 0.064 | 0.800 |
Size of primary carcinoma(≥3 cm) | 15 | 60 (9/15) | ||
Histodifferentiation(II) | 26 | 96.2 (25/26) | 12.161 | 0.002* |
Histodifferentiation(III) | 7 | 57.2 (4/7) | ||
Histodifferentiation(IV) | 12 | 50 (6/12) | ||
Lymph nodes metastasis Negative | 20 | 65 (13/20) | 16.071 | 0.000* |
Lymph nodes metastasis Positive | 25 | 88 (22/25) | ||
pTNM stage I | 9 | 22.2 (2/9) | 23.377 | 0.000* |
pTNM stage II | 11 | 72.7 (8/11) | ||
pTNM stage III | 12 | 100 (12/12) | ||
pTNM stage IV | 13 | 100 (13/13) | ||
Normal tissue | 27 | 0 (0/27) |